These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31638571)

  • 21. Interleukin-6-type cytokines and their receptors for gene therapy of melanoma.
    Mackiewicz A; Wiznerowicz M; Roeb E; Nowak J; Pawlowski T; Baumann H; Heinrich PC; Rose-John S
    Ann N Y Acad Sci; 1995 Jul; 762():361-73; discussion 373-4. PubMed ID: 7668537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field.
    Hisano S; Sakamoto K; Ishiko T; Kamohara H; Ogawa M
    Cytokine; 1997 Jun; 9(6):447-52. PubMed ID: 9199879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum soluble IL-6 receptor levels during the mobilization of stem cells to peripheral blood.
    Omura H; Kawatani T; Tajima F; Ishiga K; Ohmura H; Kawasaki H; Nanba E
    Leuk Lymphoma; 2002 Mar; 43(3):623-30. PubMed ID: 12002769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6 and soluble interleukin-6 receptor are elevated in large-vessel vasculitis: a cross-sectional and longitudinal study.
    Pulsatelli L; Boiardi L; Assirelli E; Pazzola G; Muratore F; Addimanda O; Dolzani P; Versari A; Casali M; Magnani L; Pignotti E; Pipitone N; Croci S; Meliconi R; Salvarani C
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):102-110. PubMed ID: 28466804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia.
    Goette NP; Lev PR; Heller PG; Glembotsky AC; Chazarreta CD; Salim JP; Molinas FC; Marta RF
    Exp Hematol; 2010 Oct; 38(10):868-876.e1. PubMed ID: 20600579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy.
    Hoheisel G; Izbicki G; Roth M; Chan CH; Reichenberger F; Schauer J; Perruchoud AP
    Respiration; 1998; 65(3):183-6. PubMed ID: 9670298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in sIL-6R and sTNF-Rs release by PMNs and the serum levels in breast cancer patients at different stages of treatment.
    Jablonska E
    Cytokine; 1998 Jul; 10(7):540-3. PubMed ID: 9702418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
    J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
    Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease.
    Hosokawa T; Kusugami K; Ina K; Ando T; Shinoda M; Imada A; Ohsuga M; Sakai T; Matsuura T; Ito K; Kaneshiro K
    J Gastroenterol Hepatol; 1999 Oct; 14(10):987-96. PubMed ID: 10530495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group.
    Pulkki K; Pelliniemi TT; Rajamäki A; Tienhaara A; Laakso M; Lahtinen R
    Br J Haematol; 1996 Feb; 92(2):370-4. PubMed ID: 8603002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble interleukin 6 receptor levels are associated with reduced myocardial reperfusion after percutaneous coronary intervention for acute myocardial infarction.
    Groot HE; Hartman MH; Gu YL; de Smet BJ; van den Heuvel AF; Lipsic E; van der Harst P
    Cytokine; 2015 Jun; 73(2):207-12. PubMed ID: 25792278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverse correlation of interleukin-6 with soluble interleukin-6 receptor after transplantation of bone marrow or peripheral blood stem cells.
    Steffen M; Pichlmeier U; Zander A
    Bone Marrow Transplant; 1997 Nov; 20(9):715-20. PubMed ID: 9384472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of peripheral blood cytokine and immunoglobulin detection in ACTH therapy for the treatment of infantile spasms.
    Wang X; Huang Q; Wu L; Yang Y; Ye X; Yang B
    Front Pediatr; 2024; 12():1365917. PubMed ID: 39055621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer.
    Won HS; Kim YA; Lee JS; Jeon EK; An HJ; Sun DS; Ko YH; Kim JS
    Cancer Invest; 2013 Oct; 31(8):516-21. PubMed ID: 23902164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients.
    Sasayama D; Wakabayashi C; Hori H; Teraishi T; Hattori K; Ota M; Ishikawa M; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2011 Nov; 45(11):1439-44. PubMed ID: 21700295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma.
    Kyrtsonis MC; Dedoussis G; Zervas C; Perifanis V; Baxevanis C; Stamatelou M; Maniatis A
    Br J Haematol; 1996 May; 93(2):398-400. PubMed ID: 8639436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
    Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab.
    Diaz-Torne C; Ortiz MDA; Moya P; Hernandez MV; Reina D; Castellvi I; De Agustin JJ; Fuente D; Corominas H; Sanmarti R; Zamora C; Cantó E; Vidal S
    Semin Arthritis Rheum; 2018 Jun; 47(6):757-764. PubMed ID: 29157669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.